Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-06

Clinical Trial Update: Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism [Phase 3]

View source ↗

Summary

Phase 3 trial comparing different doses of radioactive iodine (I-131) for severe Graves' hyperthyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iodine-131 (Iodine-131)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Graves Disease | Phase 3 | Status: COMPLETED